127 related articles for article (PubMed ID: 5446374)
1. L-dopa-induced accumulation of 3-O-metyldopa in brain and heart.
Kuruma I; Bartholini G; Pletscher A
Eur J Pharmacol; 1970 May; 10(2):189-92. PubMed ID: 5446374
[No Abstract] [Full Text] [Related]
2. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
Ng LK; Colburn RW; Kopin IJ
J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
[No Abstract] [Full Text] [Related]
3. 3-O-methyldopa, a new precursor of dopamine.
Bartholini G; Kuruma I; Pletscher A
Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759
[No Abstract] [Full Text] [Related]
4. The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.
Porter CC; Totaro JA; Burcin A
J Pharmacol Exp Ther; 1965 Oct; 150(1):17-22. PubMed ID: 5853698
[No Abstract] [Full Text] [Related]
5. Effects of chronic amphetamine intoxication on the accumulation in the rat brain of labelled catecholamines synthesized from circulating tyrosine- 14 C and Dopa- 3 H.
Lewander T
Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(3):211-33. PubMed ID: 4257112
[No Abstract] [Full Text] [Related]
6. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Weiss BF; Roel LE; Munro HN; Wurtman RJ
Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
[No Abstract] [Full Text] [Related]
7. Modification by L-DOPA methylester (H 19-61) of amphetamine-induced brain catecholamine changes, thermal responses and toxicity in developing mice.
Alhava E
Acta Pharmacol Toxicol (Copenh); 1973; 33(5):330-47. PubMed ID: 4801079
[No Abstract] [Full Text] [Related]
8. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
Landsberg L; Bruno SJ
Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
[No Abstract] [Full Text] [Related]
9. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
Cohen Y; Wepierre J; Jacquot C; Rapin J
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
[No Abstract] [Full Text] [Related]
10. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
Landsberg L
Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
[No Abstract] [Full Text] [Related]
11. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
12. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
Rivera-Calimlim L
Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
[TBL] [Abstract][Full Text] [Related]
13. The effect of levodopa on the norepinephrine stores in rat heart.
Liu PL; Krenis LJ; Ngai SH
Anesthesiology; 1971 Jan; 34(1):4-8. PubMed ID: 5540365
[No Abstract] [Full Text] [Related]
14. Effect of false transmitters on norepinephrine synthesis.
Kopin IJ; Weise VK; Sedvall GC
J Pharmacol Exp Ther; 1969 Dec; 170(2):246-52. PubMed ID: 4311320
[No Abstract] [Full Text] [Related]
15. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
Ng KY; Colburn RW; Kopin IJ
Nature; 1971 Apr; 230(5292):331-2. PubMed ID: 5549411
[No Abstract] [Full Text] [Related]
16. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
17. Dopamine: mediator of brain polysome disaggregation after L-dopa.
Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
[TBL] [Abstract][Full Text] [Related]
18. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
Porter CC; Torchiana ML
Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
[No Abstract] [Full Text] [Related]
19. Drugs affecting monoamines in the basal ganglia.
Bartholini G; Pletscher A
Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
[No Abstract] [Full Text] [Related]
20. Regional differences in the long-term effect of neonatal 6-hydroxydopa treatment on rat brain noradrenaline.
Zieher LM; Jaim-Etcheverry G
Brain Res; 1973 Sep; 60(1):199-207. PubMed ID: 4744760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
